Control and reference reagents
Joint Authority of the Helsinki and Uusimaa Hospital District · Uusimaa, koko Suomi
Perustiedot
- Hankkija
- Joint Authority of the Helsinki and Uusimaa Hospital District, Y-tunnus 1567535-0
- Toteutuspaikka
- Uusimaa (FI1B1), koko Suomi
- Hankintalaji
- Tavarahankinta
- Menettely
- EU-hankinta
- Ilmoituksen tyyppi
- Jälki-ilmoitus
- Sopimusten kokonaisarvo
- 19 000 € (alv 0 %)
- Erät
- 3 erää
- Pääasiallinen CPV
- 33696500 Laboratorioreagenssit
- Julkaistu
- 20.8.2023
Hankinnan tulos
| Erä | Voittaja | Sopimusarvo | Tarjouksia | Päätös |
|---|---|---|---|---|
| Erä 1 | Oxford Gene Technology | 19 000 € | 1 | |
| Erä 2 | Ei voittajaa | – | ei ilmoitettu | |
| Erä 3 | Ei voittajaa | – | ei ilmoitettu |
Voittajista näytetään nimi ja Y-tunnus. ”Ei ilmoitettu” tarkoittaa, ettei ilmoituksessa ole tätä tietoa erälle tai sopimukselle.
Ilmoituksen teksti
Alkuperäinen teksti Hilmasta, muuttamattomanaThis public tender process is for control and reference reagents for HUS Diagnostic Center, Laboratory of Genetics at Helsinki University Hospital.
The controls and reference reagents must be suitable for the laboratory process by array-CGH, NGS, real-time quantitative PCR (RT-qPCR), fragment analysis and gel electrophoresis.
The tender is divided into three lots:
1. Reference materials,
2. Quantitative PCR standards, and
3. DNA molecular weight markers and ladders.
Every lot is also divided into individual products and product groups. Partial tenders within lots are allowed. The procurement entity selects one (1) supplier for each product so that the products may have either the same or a different supplier.
The contracts with suppliers are in force for a fixed period of three (3) years, and thereafter until terminated.
Erien kuvaukset
Erä 1
This lot applies to Reference materials. Partial tenders inside the lot are accepted.
Final selection is made on a product by product basis. Only for product positions 2.1.1-2.1.2 and 2.2.1-2.2.2 for product group "Controls for fusion transcripts" and product positions 3.1-3.2 product group "Human genomic DNA" the selection shall be made by product group.
The requirements are further specified in the call for tenders and its annexes.
Erä 2
This lot applies to quantitative PCR standards. Partial tenders inside the lot are accepted.
If the tenderer offers in lot 2, the tenderer shall offer at least six (6) products. Final selection is made on a product by product basis.
The requirements are further specified in the call for tenders and its annexes.
Erä 3
This lot applies to DNA molecular weight markers and ladders. Partial tenders inside the lot are accepted.
Final selection is made on a product by product basis. Only for product positions 9.1-9.2 for product group "FlashGels" the selection shall be made by product group.
The requirements are further specified in the call for tenders and its annexes.
Erät
| Erä | Nimi | Ammattiala | Arvioitu arvo | CPV |
|---|---|---|---|---|
| 1 | – | – | – | 33696500 |
| 2 | – | – | – | 33696500 |
| 3 | – | – | – | 33696500 |
Hankinnan vaiheet
-
Tarjouspyyntö julkaistiin, määräaika 8.2.2023 klo 12.00.
-
Jälki-ilmoitustämä ilmoitus
Voittaja: Oxford Gene Technology.